Switch to Aflibercept in Diabetic Macular Edema Patients Unresponsive to Previous Anti-VEGF Therapy

Purpose. The aim was to evaluate the efficacy of aflibercept in patients with diabetic macular edema (DME) unresponsive to prior anti-VEGF therapy. Methods. Retrospective review of DME unresponsive to previous anti-VEGF switched to aflibercept with 3 months of follow-up. Changes in best correct visu...

Full description

Saved in:
Bibliographic Details
Published in:J Ophthalmol
Main Authors: Mira, Filipe, Paulo, Manuel, Henriques, Filipe, Figueira, João
Format: Artigo
Language:Inglês
Published: Hindawi 2017
Subjects:
Clinical Study
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5350533/
https://ncbi.nlm.nih.gov/pubmed/28348885
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2017/5632634
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items